Warning Letter

USFDA restricts imports of 11 Viatris drugs made in Indore facility

Read more

Lupin announces resolution of USFDA warning letter for its two facilities

Read more

US FDA issues warning letter to Lupin for Maharashtra-based API plant

Read more

Aurobindo Pharma receives Sebi’s warning letter over ongoing US FDA audit

Read more

Aurobindo Pharma gets warning letter from US FDA for API facility

Read more

Lupin gets warning letter from US FDA for Somerset facility

Read more

US FDA issues warning letter to Shilpa Medicare for Jadcherla facility, Telangana

Read more

Panacea Biotec gets warning letter from US FDA for Baddi facility

Read more

US FDA issues warning letter to Glenmark for its Baddi facility

Read more

Lupin gets warning letter from US FDA for Mandideep facility

Read more